ENSG00000204478 (PRAMEF20)

homo sapiens

PRAME family member 20

Filter your results

Kingdom
Species
Experiment type
Experimental variables
Regulation
-1.5
-4
1.3
5.9
Display log2-fold change
Download results
Log2-fold changeSpeciesGene nameComparisonExperimental variablesExperiment name
Adjusted p-valueLog2-fold change
1.1487 × 10-245.9
PRAMEF20'facioscapulohumeral dystrophy; FSDH2 mutation' vs 'normal' in 'myotube'disease, genotype, organism partDUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle
Adjusted p-valueLog2-fold change
4.2681 × 10-12-4
PRAMEF20'colorectal carcinoma' vs 'normal'block, diseaseRNA-seq of blood platelets from six tumor types and healthy donors
Adjusted p-valueLog2-fold change
5.714 × 10-11-3.8
PRAMEF20'breast carcinoma' vs 'normal'block, diseaseRNA-seq of blood platelets from six tumor types and healthy donors
Adjusted p-valueLog2-fold change
2.82 × 10-23.7
PRAMEF20'triple-negative breast cancer; breast carcinoma' vs 'normal'clinical information, diseaseRNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples
Adjusted p-valueLog2-fold change
7.0037 × 10-32.8
PRAMEF20'ML792; 400 nanomolar; 48 hour' vs 'dimethyl sulfoxide; 48 hour'compound, timeInfluence of SUMOylation on transcriptional signature of hIPSCs (ChiPS4) assessed by time-resolved RNA-seq in response to ML792 treatment
Adjusted p-valueLog2-fold change
3.2956 × 10-32.6
PRAMEF20'501Mel; shBRG1 knockdown' vs '501Mel; control'cell line, phenotypeBRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq)
Adjusted p-valueLog2-fold change
1.4008 × 10-6-2.5
PRAMEF20'non-small cell lung carcinoma' vs 'normal'block, diseaseRNA-seq of blood platelets from six tumor types and healthy donors
Adjusted p-valueLog2-fold change
1.8428 × 10-4-2.2
PRAMEF20'pancreatic adenocarcinoma' vs 'normal'block, diseaseRNA-seq of blood platelets from six tumor types and healthy donors
Adjusted p-valueLog2-fold change
5.2636 × 10-61.7
PRAMEF20'differentiated; hAKPC-P' vs 'undifferentiated; hIPod'cell type, phenotypeDifferentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes
Adjusted p-valueLog2-fold change
7.5736 × 10-61.7
PRAMEF20'differentiated; hAKPC-P' vs 're-differentiated; hIPod'cell type, phenotypeDifferentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes
Adjusted p-valueLog2-fold change
1.0755 × 10-51.5
PRAMEF20'differentiated; hAKPC-P' vs 'undifferentiated; hAKPC-P'cell type, phenotypeDifferentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes
Adjusted p-valueLog2-fold change
4.6071 × 10-3-1.5
PRAMEF20'glioblastoma' vs 'normal'block, diseaseRNA-seq of blood platelets from six tumor types and healthy donors
Adjusted p-valueLog2-fold change
2.9588 × 10-2-1.5
PRAMEF20'hepatobiliary carcinoma' vs 'normal'block, diseaseRNA-seq of blood platelets from six tumor types and healthy donors
Adjusted p-valueLog2-fold change
1.5916 × 10-31.3
PRAMEF20'diabetes mellitus' vs 'normal'diseaseAn integrative analysis of skeletal muscle insulin resistance